Safoora Aamir, Azeem Taj, Tafazzul-e haque Mahmud, Abdul Shakoor, Zafar Iqbal, Faryal Yaqub, Farhan Pasha Khan.
Interferon Alfa and Ribavirin Induced Hair Changes.
Proceeding Shaikh Zayed Postgrad Med Comp Jan ;21(1):5-9.

Combination therapy oflnterferon alfa and ribavirin in chronic hepatitis C has well documented cutaneous adverse effects. Most interesting of these has been reported on hair physiology. This study was conducted to detennine the frequency and pattern of adverse effects involving hair in patients receiving combination of interferon alfa 2a and ribavirin for chronic hepatitis C. The study was conducted in Department of Dermatology, Division of Medicine Shaikh Zayed Hospital. Thirty Eight patients who completed treatment with interferon alfa \3 MIU subcutaneously thrice weekly) and 1200 mg ribavirin daily for 24 weeks were enrolled in this single-center study. The patient's response and examination finding particularly regarding involvement of hair was noted on a Pro fonna. Thirty Two out of thirty eight (84%) patients noted adverse effects involving hair. The most frequent was diffuse hair loss and occurred in 27 patients (71 %). Hypertrichosis of eyelashes (trichomegaly) and eyebrows (synophyrs) was observed in 18 ( 47%) and 16 ( 42%) patients respectively. Graying of hair was noted in 4 patients (11 %), while discoloration of moustache hair was seen in 2 patients (5%). Epilation at the site of subcutaneous injection was noted in I 0 patients (26%). Alopecia areata was reported in 2 patients (5%). It is concluded that adverse effects involving hair are frequent and varied (hair loss to excess hair growth) during combination therapy with Interferon alfa-2a and Ribavirin for chronic hepatitis C.

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com